title: [Peculiarities of clinical course, diagnostics and treatment of overactive bladder in men older than 60 years].
abstract: The article presents the issues of the characteristics of the course, diagnostics and treatment of hyperactive urinary bubble in older men. Conservative treatment of urinary incontinence includes changes in lifestyle, behavioural and medical therapy with m-anticholinergic drugs. The combination solifenacini in a dose of 5 mg/day and α1-adrenoceptor blocking agent terasolini in a dose of 2 mg/day significantly improves the results of treatment and well tolerated.
authors.forename: S O
authors.initials: SO
authors.lastname: Sosnovskiĭ
authors.forename: V Kh
authors.initials: VKh
authors.lastname: Kheĭfets
authors.forename: O F
authors.initials: OF
authors.lastname: Kagan
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D008875:Middle Aged; D011224:Prazosin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D011470:Prostatic Hyperplasia / Q000150:complications; D011472:Prostatitis / Q000150:complications; D011812:Quinuclidines / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D000069464:Solifenacin Succinate; D044005:Tetrahydroisoquinolines / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D016896:Treatment Outcome; D053201:Urinary Bladder, Overactive / Q000175:diagnosis* / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D014563:Urodynamics / Q000187:drug effects; D064804:Urological Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D011812:Quinuclidines; D044005:Tetrahydroisoquinolines; D064804:Urological Agents; C041226:Terazosin; D000069464:Solifenacin Succinate; D011224:Prazosin